Clinical Classification of BRCA1 DNA Missense Variants: H1686Q Is a Novel Pathogenic Mutation Occurring in the Ontogenetically Invariant THV Motif of the N-Terminal BRCT Domain
- 1 September 2008
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (25) , 4212-4214
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The clinical management of BRCA1 and BRCA2 mutation carriersCurrent Oncology Reports, 2008
- BRCA1 p.Val1688del Is a Deleterious Mutation That Recurs in Breast and Ovarian Cancer Families From Northeast ItalyJournal of Clinical Oncology, 2008
- Does the Search for Large Genomic Rearrangements Impact BRCAPRO Carrier Prediction?Journal of Clinical Oncology, 2007
- Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer familiesBreast Cancer Research and Treatment, 2007
- A recurrent mutation in PALB2 in Finnish cancer familiesNature, 2007
- Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility allelesNature Genetics, 2006
- Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast CancerJAMA, 2006
- BRCA1 and BRCA2: The genetic testing and the current management options for mutation carriersCritical Reviews in Oncology/Hematology, 2006
- Structural Basis for Cell Cycle Checkpoint Control by the BRCA1−CtIP Complex,Biochemistry, 2005
- Germline Mutations in BRCA1 and BRCA2 in Breast-Ovarian Families From a Breast Cancer Risk Evaluation ClinicJournal of Clinical Oncology, 2001